Pyridoxine

Pyridoxine

SCHEMBL23647341

CC(=O)O.CC(=O)O.CC(=O)O.Cc1ncc(CO)c(CO)c1O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Pyridoxine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.83
▸ ALDH1A1 P00352 5/20 0.83
▸ HPGD P15428 4/20 0.83
▸ HSD17B10 Q99714 1/20 0.83
▸ LMNA P02545 4/20 0.65
▸ KMT2A Q03164 2/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ AOX1 Q06278 1/20 0.54
▸ TRIM24 O15164 1/20 0.53
▸ TRIM33 Q9UPN9 1/20 0.53
▸ PDXK O00764 2/20 0.51
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ HIF1A Q16665 1/20 0.49
▸ GAA P10253 2/20 0.48
▸ CA1 P00915 3/20 0.44
▸ CA2 P00918 3/20 0.44
▸ CA9 Q16790 3/20 0.44
▸ HDAC1 Q13547 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridoxine SCHEMBL405402 1.00 KDM4E (0.83) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL15486045 0.98 KDM4E (0.80) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL9168156 0.98 KDM4E (0.80) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL5346680 0.92 KDM4E (0.80) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL30267871 0.91 HPGD (1.00) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL30877002 0.91 HPGD (1.00) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL3506 0.91 HPGD (1.00) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL2322958 0.91 HPGD (1.00) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL31514964 0.90 KDM4E (0.77) KDM4EALDH1A1HPGDHSD17B10LMNA
Pyridoxine SCHEMBL4576970 0.90 KDM4E (0.77) KDM4EALDH1A1HPGDHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230000807-A1 CBD ORAL FORMULATION CLEAR LAKE RESEARCH, LLC 2023-01-05 — — US claimed
WO-2021146735-A1 CBD ORAL FORMULATION CLEAR LAKE RESEARCH, LLC (US) 2021-07-22 — — WO claimed
US-20230149303-A1 BUCCAL AND ENTERIC DELIVERY OF FATTY ACIDS IN FOODS AND BEVERAGES CLEAR LAKE RESEARCH, LLC 2023-05-18 — — US disclosed
US-20230000807-A1 CBD ORAL FORMULATION CLEAR LAKE RESEARCH, LLC 2023-01-05 — — US disclosed
US-20230000807-A1 CBD ORAL FORMULATION CLEAR LAKE RESEARCH, LLC 2023-01-05 — — US disclosed
WO-2021178465-A1 BUCCAL AND ENTERIC DELIVERY OF FATTY ACIDS WITH ORAL HYGIENE PRACTICES CLEAR LAKE RESEARCH, LLC (US) 2021-09-10 — — WO disclosed
WO-2021146735-A1 CBD ORAL FORMULATION CLEAR LAKE RESEARCH, LLC (US) 2021-07-22 — — WO disclosed
WO-2021146735-A1 CBD ORAL FORMULATION CLEAR LAKE RESEARCH, LLC (US) 2021-07-22 — — WO disclosed
Send feedback